tag:blogger.com,1999:blog-7857054149675424609.post5276576943583420898..comments2024-02-24T08:58:08.581+00:00Comments on RNAi Therapeutics: mdRNA Wants to be Opportunistic, Does not Rule out Further Participation in Sector ConsolidationDirk Hausseckerhttp://www.blogger.com/profile/18320439857875629714noreply@blogger.comBlogger3125tag:blogger.com,1999:blog-7857054149675424609.post-10663935841962581472010-05-04T04:46:33.142+00:002010-05-04T04:46:33.142+00:00What do you think of the recent news that Santaris...What do you think of the recent news that Santaris is suing Mirrx?Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-81299339747145056212010-05-02T17:25:09.132+00:002010-05-02T17:25:09.132+00:00Not sure whether this would be on top of their min...Not sure whether this would be on top of their mind if they indeed wanted to study microRNA inhibition. But if it was, my guess would be as good as anybody's.Dirk Hausseckerhttps://www.blogger.com/profile/18320439857875629714noreply@blogger.comtag:blogger.com,1999:blog-7857054149675424609.post-71709475335871097682010-05-02T16:52:28.208+00:002010-05-02T16:52:28.208+00:00Which companies would mdRNA likely work with on mi...Which companies would mdRNA likely work with on microRNA inhibition?Anonymousnoreply@blogger.com